Viking Therapeutics, Inc. (0VQA) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Viking Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.357 As a reminder, this conference call is being recorded today, April 23rd, 2025. 00:00:05.357 -- 00:00:10.604 I would now like to turn the conference over to Vikings Manager of Investor 00:00:10.604 -- 00:00:15.447 Relations, Stephanie Diaz. Please go ahead, Stephanie. 00:00:16.511 -- 00:00:19.494 Hello, and thank you for participating in today's call. 00:00:19.494 -- 00:00:24.841 Joining me today is Brian Lynn, Vikings President and CEO, and Greg Zanti, Vikings 00:00:24.841 -- 00:00:29.459 CFO. Before we begin, I'd like to caution that comments made during this conference call 00:00:29.459 -- 00:00:32.362 today, April 23rd, 2025, 00:00:32.362 -- 00:00:36.307 will contain forward-looking statements under the Safe Harbor provisions of the U.S. 00:00:36.307 -- 00:00:40.031 Securities Litigation Reform Act of 1995, including 00:00:40.031 -- 00:00:45.156 statements about Viking's expectations regarding its development activities, timelines, 00:00:45.156 -- 00:00:49.521 and milestones. Forward-looking statements are subject to risks and uncertainties that 00:00:49.521 -- 00:00:54.624 could cause actual results to differ materially and adversely and reported results 00:00:54.624 -- 00:00:58.608 should not be considered as an indication of future performance. 00:00:58.608 -- 00:01:02.933 These forward-looking statements speak only as of today's date, and the company undertakes 00:01:02.933 -- 00:01:07.018 no obligation to revise or update any statement made today. 00:01:07.018 -- 00:01:10.922 I encourage you to review all of the company's filings for the Securities and Exchange 00:01:10.922 -- 00:01:13.866 Commission concerning these and other matters. 00:01:13.866 -- 00:01:18.209 I'll now turn the call over to Brian Land for his initial co...